|
Conflict of Interest
Citations 21-30 of 151 total displayed.
|
Past content
(since Apr 1998):
|
- Letters
Incomplete Financial Disclosure in a Commentary on Testing for Fragile X Gene Mutations Throughout the Life Span
- Paul J. Hagerman
JAMA 2009; 301: 601-b-602-b.
[Extract]
[Full text]
[PDF]
[ Original Article ]
- Commentaries
Why Guideline-Making Requires Reform
- Allan D. Sniderman; Curt D. Furberg
JAMA 2009; 301: 429-431.
[Extract]
[Full text]
[PDF]
- Letters
Failure to Report Financial Disclosure Information
- Grace Lu-Yao; Peter Albertsen; Weichung Shih; Siu-Long Yao
JAMA 2009; 301: 35-b-36-b.
[Extract]
[Full text]
[PDF]
[ Original Article ]
- Capitol Health Call
Industry Funding
- Mike Mitka
JAMA 2008; 300: 2599.
[Extract]
[Full text]
[PDF]
- Book and Media Reviews
Hooked: Ethics, the Medical Profession, and the Pharmaceutical Industry
- Bernd Wollschlaeger
JAMA 2008; 300: 2675-2676.
[Extract]
[Full text]
[PDF]
- Letters
Review of The Invisible Cure—Reply
- Edward C. Green
JAMA 2008; 300: 2485-a.
[Extract]
[Full text]
[PDF]
- Letters
Review of The Invisible Cure
- Helen Epstein
JAMA 2008; 300: 2485.
[Extract]
[Full text]
[PDF]
- Letters
Issues Behind Disclosure of Conflicts of Interest
- Ronald S. Go
JAMA 2008; 300: 2120-a.
[Extract]
[Full text]
[PDF]
- Research Letters
Updated Estimates of Pharmaceutical Company Payments to Physicians in Vermont
- Joseph S. Ross; Alexander G. Nazem; Peter Lurie; Josh E. Lackner; Harlan M. Krumholz
JAMA 2008; 300: 1998-a-2000-a.
[Extract]
[Full text]
[PDF]
- Letters
Incomplete Financial Disclosures
- Robert R. Wolfe; Sharon L. Miller
JAMA 2008; 300: 1763-c.
[Extract]
[Full text]
[PDF]
[ Original Article ]
|
|
